STOCK TITAN

Sotera Health Appoints Richard Kyle to the Board of Directors

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
management

Sotera Health (Nasdaq: SHC) appointed Richard G. Kyle to its Board of Directors effective Feb 5, 2026. Mr. Kyle will join the Leadership Development and Compensation and Nominating and Corporate Governance committees.

He served as President and CEO of Timken from May 2014 to Sept 2024, continues on Timken’s board, and has served on Sonoco’s board since 2015. He holds a B.S. in Mechanical Engineering from Purdue and an M.B.A. from Northwestern.

Loading...
Loading translation...

Positive

  • Appointee served as Timken CEO from May 2014 to Sept 2024
  • Board addition brings public company CEO and governance experience
  • Expected to strengthen compensation and governance oversight via committee roles
  • Director brings global operations and financial transformation expertise

Negative

  • None.

News Market Reaction – SHC

-2.52%
1 alert
-2.52% News Effect

On the day this news was published, SHC declined 2.52%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

CLEVELAND, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, announced today it has appointed Richard G. Kyle as a new independent director to its Board of Directors. Mr. Kyle will serve as a member of the Leadership Development and Compensation Committee and the Nominating and Corporate Governance Committee of the Board of Directors.

Most recently, Mr. Kyle served as President and Chief Executive Officer of The Timken Company (“Timken”) (NYSE: TKR), a global manufacturer of bearings, transmissions, and industrial motion products, from May 2014 to September 2024. During his tenure as CEO, Mr. Kyle led Timken’s financial transformation and strategic diversification, including expanding its industrial motion portfolio, entering new product lines, and diversifying end markets. Prior to serving as CEO, Mr. Kyle held various senior leadership roles at Timken, including Chief Operating Officer and President of multiple business segments. Earlier in his career, Mr. Kyle held leadership positions at Hubbell Incorporated and Cooper Industries. Mr. Kyle was selected to serve on Sotera Health’s Board of Directors based on his experience leading global operations, strong financial acumen, and his public company governance expertise.

“We are excited to welcome Richard to our Board of Directors,” said Michael B. Petras, Jr., Chairman and Chief Executive Officer of Sotera Health. “Richard’s leadership experience as a public company CEO and his extensive experience in operations and governance will serve as tremendous assets as we continue to grow.”

Mr. Kyle continues to serve on Timken’s Board of Directors. He has also served on the Board of Directors of Sonoco Products Company (NYSE: SON) since 2015, where he is a member of the Audit Committee and the Corporate Governance and Nominating Committee and serves as Chair of the Executive Compensation Committee. He holds a Bachelor of Science in Mechanical Engineering from Purdue University and an M.B.A. from Northwestern University.

About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.

Contacts
Jason Peterson
Vice President Investor Relations, Sotera Health
IR@soterahealth.com

Kristin Gibbs
Chief Marketing Officer, Sotera Health
kgibbs@soterahealth.com

Source: Sotera Health Company


FAQ

Who is Richard G. Kyle and why did Sotera Health (SHC) appoint him on Feb 5, 2026?

He is a former Timken CEO with extensive operations and governance experience. According to the company, his public company leadership and financial transformation background informed the appointment and committee assignments.

What board committees will Richard Kyle join at Sotera Health (SHC)?

Mr. Kyle will serve on the Leadership Development and Compensation and the Nominating and Corporate Governance committees. According to the company, these roles align with his governance and executive compensation experience.

How long did Richard Kyle serve as CEO of Timken and does he still serve on that board?

Mr. Kyle served as Timken CEO from May 2014 to September 2024 and continues to serve on Timken’s board. According to the company, he maintains that directorship while joining Sotera Health’s board.

Does Richard Kyle have prior board experience relevant to Sotera Health shareholders (SHC)?

Yes. He has served on Sonoco’s board since 2015 and remains on Timken’s board. According to the company, this prior board experience contributes to his governance qualifications for Sotera Health.

What are Richard Kyle’s academic qualifications relevant to his role on Sotera Health’s board (SHC)?

He holds a Bachelor of Science in Mechanical Engineering from Purdue and an M.B.A. from Northwestern. According to the company, these credentials support his technical and business leadership background.
Sotera Health Co

NASDAQ:SHC

SHC Rankings

SHC Latest News

SHC Latest SEC Filings

SHC Stock Data

4.97B
220.60M
Diagnostics & Research
Services-misc Health & Allied Services, Nec
Link
United States
BROADVIEW HEIGHTS